Facebook
Twitter
Telegram
Report an ErrorDicerna Pharmaceuticals, Inc. Financial Statements 2011-2024 | DRNA
Annual Financial Statements Dicerna Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.67 B | 1.33 B | 559 M | 211 M | 53.9 M | 133 M | 343 M | 765 M | - | - |
Shares |
74.5 M | 68.4 M | 55.6 M | 21.9 M | 20.7 M | 20.3 M | 16.1 M | 16.6 M | - | - |
Net Income |
-113 M | -120 M | -88.9 M | -60 M | -59.5 M | -62.8 M | -47.9 M | -18.5 M | -10.1 M | -8.56 M |
Revenue |
164 M | 23.9 M | 6.18 M | 2.28 M | 295 K | 184 K | - | - | 7.02 M | 7.91 M |
EBITDA |
-111 M | -127 M | -60.4 M | -59.8 M | -58.9 M | -62.3 M | -44.3 M | -16.9 M | -8.7 M | -7.14 M |
Operating Expenses |
278 M | 152 M | 67.4 M | 62.9 M | 60 M | 63.2 M | 45.1 M | - | - | - |
General and Administrative Expenses |
72.1 M | 42.8 M | 21.7 M | 25.9 M | 18.3 M | 19.2 M | 15.6 M | 5.82 M | 4.7 M | 4.82 M |
All numbers in USD currency